| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate |
1987-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1989-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a25f981d2be9a81aeb36ce5967c9b998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b17be2d761dbd869e7cf6ce903eebb3 |
| publicationDate |
1989-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4808579-A |
| titleOfInvention |
Novel monocycle β-lactam antibacterials |
| abstract |
The disclosure describes (S)-3-[2-(2-amino-4-thiazolyl)]-(Z)-2-methoxyiminoacetylamino-2-oxo-1-azetidinyliminoacetic acid and (S)-3-[2-(2-amino-4-thiazolyl)]-(Z)-2-methoxyiminoacetylamino-2-(S)-methyl-4-oxo-1-azetidinyliminoacetic acid and the cationic salts thereof which possess antibacterial activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111100033-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111100033-A |
| priorityDate |
1987-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |